BENDEKA (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the BENDEKA drug offered from Teva Pharmaceuticals USA, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
| NON-PROPRIETARY NAME: | bendamustine hydrochloride |
| SUBSTANCE NAME: | BENDAMUSTINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-12-08 |
| END MARKETING DATE: | 0000-00-00 |
BENDEKA HUMAN PRESCRIPTION DRUG Details:
| Item Description | BENDEKA from Teva Pharmaceuticals USA, Inc. |
| LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/mL) |
| START MARKETING DATE: | 2015-12-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63459-348_2fe8c905-5a19-4d9e-a720-b5a13b7d67d5 |
| PRODUCT NDC: | 63459-348 |
| APPLICATION NUMBER: | NDA208194 |
Other BENDAMUSTINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
